IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Vida Ventures Advisors, LLC

Q1 2023 Holdings

Filed 2023-04-13 | 7 holdings | $73.1M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Dyne Therapeutics, Inc.(DYN)Common Stock26818M108$25.6M2,220,03435.0%
Centessa Pharmaceuticals plc(CNTA)Ordinary Shares152309100$15.1M3,931,81820.7%
Kinnate Biopharma, Inc.Common Stock49705R105$13.8M2,207,77218.9%
Allogene Therapeutics, Inc.(ALLO)Common Stock019770106$8.9M1,798,16312.2%
LianBioOrdinary Shares53000N108$4.5M2,282,0846.1%
Kronos Bio, Inc.(KRON1USD)Common Stock50107A104$4.0M2,765,3145.5%
Praxis Precision Medicines, Inc.Common Stock74006W108$1.2M1,469,6651.6%